High resolution magnetic resonance vessel wall imaging (MRVWI) is now widely used for the risk evaluation of patients with ischemic stroke. The use of MRVWI with and without contrast agent is a diagnostic criterion from expert consensus recommendations. However, patients with renal insufficiency who receive gadolinium-based contrast agents are at risk for developing a debilitating and potentially fatal disease known as nephrogenic systemic fibrosis. The study proposes a method based on adversarial generation network to obtain enhanced MR vessel wall image without using contrast agent. The results show the enhancement effect is consistent with the contrast-enhanced MRVWI images.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords